Pharmaceutical waste system

US12434282B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12434282-B2
Application numberUS-202117643344-A
CountryUS
Kind codeB2
Filing dateDec 8, 2021
Priority dateSep 9, 2016
Publication dateOct 7, 2025
Grant dateOct 7, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of disposing of a residual pharmaceutical composition from an IV bag includes coupling the IV bag to a pharmaceutical dispenser coupler. The method also includes extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler. The method further includes treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of disposing of a residual pharmaceutical composition from an IV bag with a pharmaceutical waste system including a main housing with a security mechanism, the method comprising: coupling the IV bag to a pharmaceutical dispenser coupler; extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler; treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner; and unlocking the main housing to access the pharmaceutical waste system. 2. The method of claim 1 wherein treating at least a portion of the extracted pharmaceutical composition comprises separating the extracted pharmaceutical composition into a purified waste portion and a contaminated waste portion. 3. The method of claim 2 wherein separating the extracted pharmaceutical composition comprises filtering at least a portion of the extracted pharmaceutical composition. 4. The method of claim 3 wherein filtering is further defined as binding at least a portion of the residual pharmaceutical composition extracted from IV bag with a filter media to retain the contaminated waste portion. 5. The method of claim 4 wherein the filter media comprises activated charcoal. 6. The method of claim 1 wherein treating at least a portion of the extracted pharmaceutical composition comprises chemically treating the extracted pharmaceutical composition. 7. The method of claim 6 wherein chemically treating the extracted pharmaceutical composition comprises deactivating the extracted pharmaceutical composition, denaturing the extracted pharmaceutical composition, oxidizing the extracted pharmaceutical composition, and combinations thereof. 8. The method of claim 7 wherein chemically treating the extracted pharmaceutical composition comprises oxidizing the extracted pharmaceutical composition with a chlorine-based oxidizing agent. 9. The method of claim 1 further comprising treating at least a portion of the extracted pharmaceutical composition by oxidizing the extracted pharmaceutical composition to form an unrecoverable pharmaceutical waste, and separating the unrecoverable pharmaceutical waste between a purified waste portion and a contaminated waste portion. 10. The method of claim 1 further comprising temporarily storing at least a portion of the extracted pharmaceutical composition in a reservoir before treating the at least a portion of the extracted pharmaceutical composition. 11. The method of claim 1 further comprising coupling a second IV bag to a second pharmaceutical dispenser coupler. 12. The method of claim 1 further comprising the step of removing a replaceable cartridge including a filter media from the pharmaceutical waste system. 13. A method of disposing of a residual pharmaceutical composition from an IV bag coupled to a pharmaceutical dispenser coupler, the method comprising: extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler; separating the extracted pharmaceutical composition into a purified waste portion and a contaminated waste portion; and treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner. 14. The method of claim 13 further comprising analyzing at least a portion of the extracted pharmaceutical composition to determine a characteristic of the extracted pharmaceutical composition. 15. The method of claim 14 further comprising restricting or permitting flow of the treated pharmaceutical composition to one of a waste drain and a waste container based on the determined characteristics of the treated pharmaceutical composition. 16. The method of claim 13 wherein separating the extracted pharmaceutical composition comprises filtering at least a portion of the extracted pharmaceutical composition. 17. The method of claim 13 wherein chemically treating the extracted pharmaceutical composition comprises deactivating the extracted pharmaceutical composition, denaturing the extracted pharmaceutical composition, oxidizing the extracted pharmaceutical composition, and combinations thereof. 18. The method of claim 13 further comprising treating at least a portion of the extracted pharmaceutical composition with a light source configured to deactivate and/or denature any pharmaceutical drugs from the residual pharmaceutical composition. 19. A method of disposing of a residual pharmaceutical composition from an IV bag, the method comprising: coupling the IV bag to a pharmaceutical dispenser coupler; extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler; treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner; and analyzing at least a portion of the extracted pharmaceutical composition to determine a characteristic of the extracted pharmaceutical composition.

Assignees

Inventors

Classifications

  • Medical waste · CPC title

  • Chemical treatment, e.g. pH adjustment or oxidation (involving an extraction step B09B3/80) · CPC title

  • Destroying solid waste or transforming solid waste into something useful or harmless · CPC title

  • from the pharmaceutical industry, e.g. containing antibiotics · CPC title

  • B09B3/80Primary

    involving an extraction step · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12434282B2 cover?
A method of disposing of a residual pharmaceutical composition from an IV bag includes coupling the IV bag to a pharmaceutical dispenser coupler. The method also includes extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler. The method further includes treating at least a portion of the extracted pharmaceutical com…
Who is the assignee on this patent?
Stryker Corp
What technology area does this patent fall under?
Primary CPC classification B09B3/80. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Oct 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).